CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
InterAx Biotech has created PICARD, a drug discovery platform focused on G-Protein Coupled Receptors (GPCRs). This platform aims to enhance the identification of drug candidates, improving their efficacy and reducing side effects, thereby streamlining the drug development process for various diseases.
InterAx Biotech, a Swiss company and spin-off from the ETH Zürich and the Paul Scherrer Institute has built PICARD, a unique drug discovery platform for the identification of drug candidates with improved efficacy and reduced side effects for the largest class of human receptors:
The G-Protein Coupled Receptors (GPCRs).
These receptors play a central role in many vital biological processes and they are implicated in a large variety of human diseases.
Due to their complex nature and mechanisms th…
INTERAX BIOTECHSA INTERAX BIOTECH LTD
INTERAX BIOTECH AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
